Table 6.
Acute effect of compounds 11, 17, 25, 28 and 35 on blood glucose levels in STZ-diabetics mice.
Test samples | Blood glucose concentration(mM) |
||||||
---|---|---|---|---|---|---|---|
Dose(per os) mg/kg of bw | 0h | 1.5h | 3h | 5h | 7h | 9h | |
Control (vehicle) | – | 24.7 ± 5.8 | 22.7 ± 5.4 | 15.9 ± 4.9 | 15.4 ± 6.5 | 14.9 ± 7.1 | 15.8 ± 5.3 |
(−8.23) | (−35.63) | (−37.79) | (−39.88) | (−35.97) | |||
Glibenclamide | 10 | 16.9 ± 4.3 | 7.2 ± 4.0* | 6.9 ± 1.6 | 6.7 ± 2.5 | 6.5 ± 2.2 | 4.9 ± 2.5** |
(−55.28) | (−57.14) | (−55.90) | (−59.63) | (−70.81) | |||
11 | 10 | 24.9 ± 4.1 | 20.6 ± 5.9 | 15.5 ± 8.5 | 12.8 ± 10.4 | 11.4 ± 8.2 | 11.9 ± 8.5 |
(−17.27) | (−37.75) | (−48.59) | (−54.22) | (−52.21) | |||
11 | 30 | 25.3 ± 6.3 | 20.0 ± 6.3 | 16.5 ± 6.4 | 11.3 ± 4.0 | 9.5 ± 3.9 | 8.1 ± 4.2 |
(−20.95) | (−34.78) | (−55.41) | (−62.40) | (−68.14) | |||
11 | 100 | 23.5 ± 5.4 | 18.3 ± 3.9 | 15.3 ± 3.9 | 11.1 ± 4.4 | 8.9 ± 2.8 | 8.2 ± 2.6 |
(−21.88) | (−34.89) | (−52.76) | (−62.21) | (−65.27) | |||
17 | 10 | 26.9 ± 3.8 | 24.5 ± 3.0 | 22.8 ± 2.3 | 16.6 ± 5.8 | 14.8 ± 8.0 | 14.7 ± 9.5 |
(−8.92) | (−15.24) | (−38.29) | (−44.98) | (−45.35) | |||
17 | 30 | 23.3 ± 3.2 | 17.9 ± 5.7 | 11.6 ± 4.8 | 8.3 ± 3.8 | 7.4 ± 6.7 | 6.9 ± 7.9* |
(−23.18) | (−50.22) | (−64.38) | (−68.24) | (−70.39) | |||
17 | 100 | 23.4 ± 5.7 | 18.8 ± 6.0 | 12.5 ± 4.7 | 7.6 ± 3.8 | 6.9 ± 2.6 | 8.0 ± 2.3 |
(−19.66) | (−46.58) | (−67.52) | (−70.51) | (−65.81) | |||
25 | 10 | 19.7 ± 6.1 | 15.7 ± 6.6 | 14.9 ± 6.5 | 9.7 ± 3.4 | 6.9 ± 3.9 | 8.5 ± 2.2 |
(−20.30) | (−24.37) | (−50.76) | (−64.97) | (−56.85) | |||
25 | 30 | 24.8 ± 4.9 | 21.7 ± 3.9 | 15.8 ± 4.5 | 8.9 ± 6.3 | 9.0 ± 4.8 | 8.9 ± 3.8 |
(−12.50) | (−36.23) | (−64.11) | (−63.71) | (−64.11) | |||
25 | 100 | 23.0 ± 4.8 | 18.3 ± 3.5 | 17.2 ± 2.9 | 9.9 ± 2.7 | 8.1 ± 1.6 | 9.1 ± 2.3 |
(−20.44) | (−25.36) | (−56.95) | (−64.78) | (−60.43) | |||
28 | 10 | 15.3 ± 3.8 | 14.8 ± 5.8 | 11.4 ± 4.2 | 8.9 ± 2.6 | 6.4 ± 1.6 | 7.0 ± 2.4 |
(−3.27) | (−25.49) | (−41.83) | (−58.17) | (−54.25) | |||
28 | 30 | 18.2 ± 6.7 | 14.9 ± 6.6 | 13.5 ± 6.1 | 12.7 ± 6.7 | 10.3 ± 5.6 | 7.3 ± 4.5 |
(−18.13) | (−25.82) | (−30.22) | (−43.41) | (−59.89) | |||
28 | 100 | 18.2 ± 4.1 | 17.3 ± 6.7 | 13.0 ± 6.6 | 11.0 ± 6.4 | 11.8 ± 6.0 | 10.2 ± 4.6 |
(−4.95) | (−28.57) | (−39.56) | (−35.17) | (−43.96) | |||
35 | 10 | 20.5 ± 7.1 | 13.1 ± 6.4* | 10.7 ± 5.7 | 5.6 ± 3.1* | 5.4 ± 3.4* | 5.7 ± 3.1* |
(−36.10) | (−47.81) | (−72.68) | (−73.66) | (−72.20) | |||
35 | 30 | 21.6 ± 4.4 | 12.0 ± 3.7* | 10.5 ± 5.1 | 6.3 ± 4.3 | 5.7 ± 6.7* | 5.5 ± 5.2* |
(−44.44) | (−51.39) | (−70.83) | (−73.61) | (−74.54) | |||
35 | 100 | 20.3 ± 4.4 | 15.1 ± 5.0 | 10.5 ± 4.9 | 7.2 ± 2.6 | 7.2 ± 3.9 | 6.4 ± 2.0* |
(−25.62) | (−48.28) | (−64.53) | (−64.53) | (−68.47) |
Each value is the mean ± SEM for six mice in each group.
p < 0.05 significantly different ANOVA followed by Dunnett’s t-test for comparison with respect to initial levels in each group.
% Variation of glycemia are in parentheses.